June 9 | Washington, DC The Manufacturing Biosolutions to Strengthen Supply Chains symposium will bring together leaders from government, industry, academia, and the investment community to explore the future of U.S. biotechnology and biomanufacturing. As global supply chains face increasing pressures from geopolitical competition, economic uncertainty, and growing demand for domestic production, biotechnology is emerging as a critical tool for strengthening American manufacturing capacity,...

We had a whirlwind day last week (March 26) highlighting strategies to accelerate the commercial deployment biomanufacturing in the United States. Many thanks to Novonesis , IFF , Manus , Pivot Bio , Kula Bio , Ecovative , GALY , and POET for burning up the shoe leather (and braving cherry blossom traffic). It was also great working in collaboration with the Engineering Biology Research Consortium and Federation of American Scientists to cover dozens of offices on Capitol Hill -...

The AAB joined with 32 other leaders in the U.S. biomanufacturing sector calling for the inclusion of the biotechnology provisions in the Fiscal Year 2026 National Defense Authorization Act (NDAA). The letter notes that the National Security Commission on Emerging Biotechnology (NSCEB) concluded that: "Advances in biotechnology represent a paradigm shift in how conflicts can be fought and won. The countries that seize the moment will retain or achieve superpower status. Those that fail to do...